Hemosiderotic Fibrolipomatous Tumor
- 2 Downloads
Is a locally aggressive fibrolipomatous, hemosiderin-rich neoplasia
Rare soft tissue neoplasm
Most commonly affected sites are the dorsum of the foot and the ankle region. Less frequently effected regions include the upper limbs, hands, and the head/neck region (Marshall-Taylor and Fanburg-Smith 2000; Browne and Fletcher 2006).
Complete surgical excision is the treatment of choice.
HFLT is an ill-defined yellowish-brown tumor with a tumor size ranging from 1 to 20 cm...
References and Further Reading
- Browne, T. J., & Fletcher, C. D. (2006). Haemosiderotic fibrolipomatous tumour (so-called haemosiderotic fibrohistiocytic lipomatous tumour): Analysis of 13 new cases in support of a distinct entity. Histopathology, 48, 453–461. PMID: 16487368.Google Scholar
- Elco, C. P., Mariño-Enríquez, A., Abraham, J. A., et al. (2010). Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: Report of a case providing further evidence for a pathogenetic link. The American Journal of Surgical Pathology, 34, 1723–1727. PMID: 20871391.PubMedGoogle Scholar
- Hallor, K. H., Sciot, R., Staaf, J., et al. (2009). Two genetic pathways, t(1;10) and amplification of 3p11–12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. The Journal of Pathology, 217, 716–727. PMID: 19199331.CrossRefGoogle Scholar
- Marshall-Taylor, C., & Fanburg-Smith, J. C. (2000). Hemosiderotic fibrohistiocytic lipomatous lesion: Ten cases of a previously undescribed fatty lesion of the foot/ankle. Modern Pathology, 13, 1192–1199. PMID: 11106076.Google Scholar